Cardiomarkers Evaluation and Myocardial Assessment in Patients With Recanalization of Chronic Total Occlusions Using High Dose Atorvastatin Loading

Complex Issues of Cardiovascular Diseases
doi 10.17802/2306-1278-2018-7-1-29-35
Full Text
Abstract

Available in full text

Date
Authors
Publisher

NII KPSSZ

Related search

Recanalization of Chronic Total Coronary Artery Occlusions – The Role of Multi-Slice Computed Tomography.

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2011English

Endovascular Recanalization of Superficial Femoral Artery Chronic Total Occlusions: A Multi-Disciplinary, Single Center Experience

2017English

Chronic Total Occlusions: The Challenges in Interventional Cardiology

Cardiologia Croatica
Cardiovascular MedicineCardiology
2020English

Direct Assessment of Coronary Steal and Associated Changes of Collateral Hemodynamics in Chronic Total Coronary Occlusions

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

A Comparison of the Effects of Aggressive Dose and Conventional Dose Atorvastatin Applications on IL-6 and NO Levels in Patients With Acute Myocardial Infarction

African Journal of Pharmacy and Pharmacology
2011English

Evaluation of Left Ventricular Function After Percutaneous Recanalization of Chronic Coronary Occlusions: The Role of Two-Dimensional Speckle Tracking Echocardiography

World Journal of Cardiovascular Diseases
2019English

Contemporary Indications for Percutaneous Revascularization of Coronary Chronic Total Occlusions

Vessel Plus
2019English

Efficacy of Short-Term High-Dose Atorvastatin for Prevention of Contrast-Induced Nephropathy in Patients With ST Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Heart
Cardiovascular MedicineCardiology
2011English

Predictors of Successful Percutaneous Coronary Intervention in Chronic Total Coronary Occlusions

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy